A Trial for Systemic Light-chain (AL) Amyloidosis

NCT01277016 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

110

Enrollment

NETWORK

Sponsor class

Conditions

AL Amyloidosis

Interventions

DRUG: BMDex

Sponsor

European Myeloma Network B.V.